Full Press Release Details
Immatics Announces Proposed $150 Million Public Offering.
IMTX
Immatics Announces Proposed $150 Million Public Offering
Key Takeaway: Immatics Announces Proposed $150 Million Public Offering
Price reaction · baseline $11.07 (2024-10-09 close) · hit after-hours · 1 other IMTX headline(s) in the window, move may be shared
day 0 close
-15.6%
day 1 · peak
-15.6%
day 3
-14.3%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+20%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Lead asset
IMA401
Phase 1 · Refractory Cancer